SCHEMBL4853536

SCHEMBL4853536

CCC(O)CONC(=O)c1ccc(F)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.44
TAS1R1 Q7RTX1 2/20 0.44
ALDH1A1 P00352 2/20 0.43
MAP2K1 Q02750 6/20 0.42
MAP2K2 P36507 2/20 0.42
MAPK1 P28482 2/20 0.42
BRAF P15056 1/20 0.42
MAP2K5 Q13163 1/20 0.42
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
TRPA1 O75762 1/20 0.41
CHRNA1 P02708 1/20 0.40
CHRNG P07510 1/20 0.40
CHRNB1 P11230 1/20 0.40
CHRNB2 P17787 1/20 0.40
SLC6A2 P23975 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4861222 0.87 CHRNA1 (0.44) TAS1R3TAS1R1ALDH1A1MAP2K1CES2
SCHEMBL4859968 0.85 MAPK1 (0.39) TAS1R3TAS1R1ALDH1A1MAP2K1MAP2K2
SCHEMBL5395452 0.81 TRPA1 (0.46) TAS1R3TAS1R1ALDH1A1MAP2K1CES2
SCHEMBL5396300 0.78 CES2 (0.43) TAS1R3TAS1R1ALDH1A1CES2CES1
SCHEMBL4859235 0.78 CES2 (0.46) TAS1R3TAS1R1ALDH1A1MAPK1CES2
SCHEMBL6291672 0.77 MAP2K1 (0.50) MAP2K1MAP2K2MAPK1BRAFMAP2K5
SCHEMBL29777573 0.75 CES2 (0.53) TAS1R3TAS1R1ALDH1A1MAPK1CES2
SCHEMBL5379829 0.75 CES2 (0.53) TAS1R3TAS1R1ALDH1A1MAPK1CES2
SCHEMBL4862621 0.74 KMT2A (0.42) TAS1R3TAS1R1ALDH1A1MAPK1CES2
SCHEMBL5384518 0.74 CHRNA1 (0.49) TAS1R3TAS1R1CES2CES1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7411001-B2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY (US) 2008-08-12 US disclosed
US-20050176820-A1 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids WARNER-LAMBERT COMPANY 2005-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176820-A1 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids CYP4X1, CYP2A7, CYP4B1 TAS1R3 3582/4885TAS1R1 3715/4885ALDH1A1 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.